Two recent scientific advances underscore an encouraging future for precision medicine at FDA


11 July 2017 - FDA helps bring precision medicine – in the form of targeted therapies — to people living with diseases that have specific genetic features.

Two recent FDA drug approvals point to an encouraging future for “precision medicine” — an approach for disease treatment that tailors medical therapies, including medications, to the needs of individual patients. 

These approvals involve diseases resulting from particular genetic characteristics identified by laboratory testing.

Read FDA blog

Michael Wonder

Posted by:

Michael Wonder